Clinical trial to study the efficacy of two drugs Sankhapushpi and Jatamansi powder to treat patients with Anxiety Disorder.

Comparative clinical study on efficacy of Sankhapushpi and Jatamansi churna in Chittodvega with special reference to Generalized Anxiety Disorder.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080426

Enrollment

Registered

2025-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group 18 to 50yrs both male and female having anxiety of minimum 6 months duration fulfilling the diagnostic criteria DSM4/DSM5 or atleast 14 on the Hamilton anxiety rating scale.

Exclusion criteria

Exclusion criteria: 1.Patient below 18 yrs and above 50 yrs. 2.Patient with major Psychiatric illness like Schizophrenia, Depressive psychosis, Epilepsy etc. 3.Patient like Lactating mothers, Pregnant women, medical condition like Hypothyroidism etc. 4.Patients with acute illness like CVA,CCF,MI etc.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Sankhapushpi and Jatamansi churna in Generalized anxiety disorder(Chittodvega).Timepoint: 45 days	—

Secondary

Measure	Time frame
Assessment will be done according to improvement in the anxiety rating scale.Timepoint: 15,30,45 days.	—

Countries

India

Contacts

Public ContactDr Kanika Goswami

Govt Ayurvedic college and Hospital Ghy 14

dr.kanikagoswami2010@gmail.com9864032837

Outcome results